Wellinks
Provides a virtual care platform for people with chronic respiratory disease, connecting patients with digital tools and clinical support.
Overview
Wellinks builds digital health tools for chronic respiratory care, with a focus on supporting people managing conditions such as COPD outside traditional clinic settings. Its platform targets patients, clinicians, and health systems seeking virtual care models for long-term respiratory management. The company’s positioning centers on a disease-specific care platform and provider partnerships rather than broad telehealth. Wellinks raised a $10 million Series B in August 2026 from UMass Memorial Health and existing investors, bringing disclosed funding to $10 million.
Funding History
Wellinks Closed $10 Million Series B Funding from UMass Memorial Health and inside investors
Frequently Asked Questions
- How much funding does AI Funding track for Wellinks?
- AI Funding tracks $10M for Wellinks across 1 funding round in this database.
- Who are Wellinks's investors?
- Wellinks's investors include UMass Memorial Health.
- What does Wellinks do?
- Wellinks builds digital health tools for chronic respiratory care, with a focus on supporting people managing conditions such as COPD outside traditional clinic settings. Its platform targets patients, clinicians, and health systems seeking virtual care models for long-term respiratory management. The company’s positioning centers on a disease-specific care platform and provider partnerships rather than broad telehealth. Wellinks raised a $10 million Series B in August 2026 from UMass Memorial Health and existing investors, bringing disclosed funding to $10 million.
- Where is Wellinks headquartered?
- Wellinks is headquartered in New Haven, USA.
Investors
Related Insights
A data-driven analysis of AI funding across all 17 sectors — from Foundation Models to AI Healthcare — with sector totals, deal counts, top companies, and investment trends for 2026.
A comprehensive, data-driven analysis of AI venture funding in Q1 2026. $25.9 billion raised across 94 deals, with 14 mega-rounds capturing 79.8% of total capital. Europe breaks out with $6.65B, and billion-dollar seed rounds arrive for the first time.
A deep comparison of Science Corp.'s neurotech-driven brain-computer interfaces and Nscale's AI cloud infrastructure, examining how $230M and $2B in recent funding fuel fundamentally different visions of artificial intelligence.